查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1653934

直接面對消費者的基因檢測市場規模、佔有率和成長分析（按檢測類型、技術、分銷管道和地區）—2025-2032 年產業預測

Direct-to-Consumer Genetic Testing Market Size, Share, and Growth Analysis, By Test Type, By Technology, By Distributional Channel, By Region - Industry Forecast 2025-2032
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2023 年直接面對消費者的基因檢測市場規模價值 21 億美元，預計將從 2024 年的 26.2 億美元成長到 2032 年的 156.5 億美元，預測期內（2025-2032 年）的複合年成長率為 25.0%。

全球直接面對消費者的基因檢測市場正在改變個人獲取基因見解的方式，促進自我發現和個人化健康。在消費者好奇心和技術進步的推動下，檢測變得越來越便宜和普及，推動了人們對預防性醫療保健的日益重視。然而，對隱私和資料安全的擔憂帶來了挑戰。為了維持消費者的信任，必須安全地處理敏感的基因資料。此外，解釋結果的複雜性可能會令人困惑。值得注意的趨勢包括將基因檢測與數位健康平台和穿戴式裝置結合，以實現即時健康監測，以及引入基因諮詢服務以便進行明智的解釋。成長機會很多，包括基因體學研究的進步、擴大研究範圍、以及加強消費者教育以培育知情市場。

目錄

介紹

  • 調查目的
  • 研究範圍
  • 定義

調查方法

  • 資訊採購
  • 次要和主要資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機會
    • 限制與挑戰
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數（2024 年）
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究分析

直接面對消費者的基因檢測市場規模（按檢測類型和複合年成長率） (2025-2032)

  • 市場概況
  • 營養基因組學測試
  • 預測測試
  • 攜帶者檢測
  • 其他

直接面對消費者的基因檢測市場規模（依技術及複合年成長率） (2025-2032)

  • 市場概況
  • 全基因組序列分析
  • 單核苷酸多態性晶片
  • 目標分析
  • 其他

直接面對消費者的基因檢測市場規模（按分銷管道和複合年成長率） (2025-2032)

  • 市場概況
  • 網路平台
  • 在商店

直接面對消費者的基因檢測市場規模（按地區分類）及複合年成長率（2025-2032）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前 5 家公司對比
  • 主要企業市場定位（2024年）
  • 主要市場參與者所採用的策略
  • 近期市場趨勢
  • 公司市場佔有率分析（2024 年）
  • 主要企業簡介
    • 公司詳細資訊
    • 產品系列分析
    • 公司分部佔有率分析
    • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

  • 23andMe（US）
  • FamilyTreeDNA（US）
  • Living DNA（UK）
  • Helix（US）
  • Color Genomics（US）
  • Orig3n（US）
  • Pathway Genomics（US）
  • Dante Labs（UK）
  • Gene by Gene（US）
  • GeneSight（US）
  • Genomics England（UK）
  • African Ancestry（US）
  • Toolbox Genomics（US）

結論和建議

簡介目錄
Product Code: SQMIG35D2092

Direct-to-Consumer Genetic Testing Market size was valued at USD 2.1 billion in 2023 and is poised to grow from USD 2.62 billion in 2024 to USD 15.65 billion by 2032, growing at a CAGR of 25.0% during the forecast period (2025-2032).

The Global Direct-To-Consumer Genetic Testing market is transforming individual access to genetic insights, fostering self-discovery and personalized wellness. Driven by consumer curiosity and technological advancements, testing has become increasingly affordable and accessible, aligning with a rising emphasis on preventive healthcare. However, privacy and data security concerns pose challenges, as sensitive genetic data require secure handling to maintain consumer trust. Additionally, complexities in interpreting results can create confusion. Notable trends include the integration of genetic testing with digital health platforms and wearables for real-time health monitoring, as well as the introduction of genetic counseling services for informed interpretation. Opportunities for growth abound, including advancements in genomic research, expanding testing scope, and enhanced consumer education to cultivate a knowledgeable market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Direct-To-Consumer Genetic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Direct-To-Consumer Genetic Testing Market Segments Analysis

Global Direct-to-Consumer Genetic Testing Market is segmented by Test Type, Technology, Distributional Channel and region. Based on Test Type, the market is segmented into Nutrigenomics Testing, Predictive Testing, Carrier Testing and Others. Based on Technology, the market is segmented into Whole Genome Sequencing, Single Nucleotide Polymorphism Chips, Targeted Analysis and Others. Based on Distributional Channel, the market is segmented into Online Platform and OTC. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Direct-To-Consumer Genetic Testing Market

A major catalyst for the growth of the direct-to-consumer genetic testing market is the rising consumer interest in personalized healthcare solutions. Individuals are increasingly taking charge of their health by seeking insights into their genetic predispositions, which helps them make informed choices about disease prevention, lifestyle modifications, and tailored treatment plans. This proactive approach is reflected in the decision of many to undergo genetic testing to evaluate their risks for hereditary conditions, such as breast cancer or Alzheimer's disease, empowering them to implement early detection strategies or preventive measures. Overall, this trend underscores a broader shift towards individualized health management.

Restraints in the Direct-To-Consumer Genetic Testing Market

The direct-to-consumer genetic testing market encounters significant regulatory and ethical hurdles. One major concern is the dissemination and interpretation of intricate genetic data to consumers independently, which raises the risk of misunderstanding or miscommunication without professional guidance. Additionally, the issues of privacy and security surrounding personal genetic information are critical, as the ease of access and commercialization could result in unauthorized use or breaches of sensitive data. Regulatory agencies are actively developing frameworks to ensure adequate oversight, protecting consumers within the rapidly evolving landscape of direct-to-consumer genetic testing while addressing these pressing challenges.

Market Trends of the Direct-To-Consumer Genetic Testing Market

The Direct-To-Consumer (DTC) genetic testing market is undergoing a significant transformation, characterized by the diversification of applications beyond traditional ancestry and genealogy testing. Companies are broadening their offerings to include health-focused insights, such as carrier status for genetic disorders, pharmacogenomic information, and wellness assessments. As consumers become more health-conscious, there is a growing demand for tests that reveal how individuals respond to specific medications, thereby enhancing personalized medicine. This trend not only empowers consumers with actionable insights related to their health but also positions DTC genetic testing as a critical component of preventive healthcare strategies, influencing market dynamics moving forward.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Study Analysis

Global Direct-to-Consumer Genetic Testing Market Size by Test Type & CAGR (2025-2032)

  • Market Overview
  • Nutrigenomics Testing
  • Predictive Testing
  • Carrier Testing
  • Others

Global Direct-to-Consumer Genetic Testing Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Whole Genome Sequencing
  • Single Nucleotide Polymorphism Chips
  • Targeted Analysis
  • Others

Global Direct-to-Consumer Genetic Testing Market Size by Distributional Channel & CAGR (2025-2032)

  • Market Overview
  • Online Platform
  • OTC

Global Direct-to-Consumer Genetic Testing Market Size & CAGR (2025-2032)

  • North America (Test Type, Technology, Distributional Channel)
    • US
    • Canada
  • Europe (Test Type, Technology, Distributional Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Test Type, Technology, Distributional Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Test Type, Technology, Distributional Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Test Type, Technology, Distributional Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • 23andMe (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FamilyTreeDNA (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Living DNA (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Helix (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Color Genomics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Orig3n (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pathway Genomics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dante Labs (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gene by Gene (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GeneSight (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genomics England (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • African Ancestry (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Toolbox Genomics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations